Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Insulet Corporation - Common Stock (NQ:PODD)

155.79 -8.69 (-5.28%)
Streaming Delayed Price Updated: 10:31 AM EDT, Jul 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 173,804
Open 163.70
Bid (Size) 155.59 (100)
Ask (Size) 156.73 (100)
Prev. Close 164.48
Today's Range 153.64 - 164.40
52wk Range 138.79 - 354.88
Shares Outstanding 68,873,869
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which S&P500 stocks are gapping on Monday? ↗
Via Chartmill
News headline image
Attention Long-Term Shareholders of Insulet Corporation (NASDAQ: PODD); Navan, Inc. (NASDAQ: NAVN); Via Transportation, Inc. (NYSE: VIA); and ZoomInfo Technologies, Inc. (NASDAQ: GTM): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire

Performance

YTD
-44.9%
-44.9%
1 Month
+1.7%
+1.7%
3 Month
-23.4%
-23.4%
6 Month
-45.1%
-45.1%
1 Year
-48.2%
-48.2%

More News

Read More
News headline image
Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless Diabetes Technology
From Insulet Corporation
Via Business Wire
News headline image
ROSEN, LEADING INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PODD
From The Rosen Law Firm PA
Via GlobeNewswire
Insulet Corp (NASDAQ:PODD): Strong Growth Stock Consolidating Near Resistance for a Potential Breakout ↗
Via Chartmill
INSULET CORP (NASDAQ:PODD) Fits the Affordable Growth Mold with Strong Momentum and Reasonable Valuation ↗
Via Chartmill
News headline image
Rosen Law Firm Urges Insulet Corporation (NASDAQ: PODD) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Law Offices of Howard G. Smith Encourages Insulet Corporation (PODD) Shareholders to Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Investor Notice: Robbins LLP Informs Investors of the Insulet Corporation Securities Class Action Lawsuit
From Robbins LLP
Via Business Wire
News headline image
Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026
From Insulet Corporation
Via Business Wire
News headline image
Patient Monitoring Stocks Q1 Earnings Review: Insulet (NASDAQ:PODD) Shines
Via StockStory
Topics Artificial Intelligence
News headline image
Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors
From Insulet Corporation
Via Business Wire
News headline image
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Avoid
Via StockStory
News headline image
1 Mid-Cap Stock Worth Your Attention and 2 We Question
Via StockStory
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
2 S&P 500 Stocks to Target This Week and 1 That Underwhelm
Via StockStory
Topics Stocks
Top S&P500 movers in Tuesday's session ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
From Insulet Corporation
Via Business Wire
Stay informed with the top movers within the S&P500 index on Friday. ↗
Via Chartmill
Which S&P500 stocks are moving on Friday? ↗
Via Chartmill
News headline image
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
From Insulet Corporation
Via Business Wire
News headline image
3 Reasons We’re Fans of Insulet (PODD)
Via StockStory

Frequently Asked Questions

Is Insulet Corporation - Common Stock publicly traded?
Yes, Insulet Corporation - Common Stock is publicly traded.
What exchange does Insulet Corporation - Common Stock trade on?
Insulet Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Insulet Corporation - Common Stock?
The ticker symbol for Insulet Corporation - Common Stock is PODD on the Nasdaq Stock Market
What is the current price of Insulet Corporation - Common Stock?
The current price of Insulet Corporation - Common Stock is 155.79
When was Insulet Corporation - Common Stock last traded?
The last trade of Insulet Corporation - Common Stock was at 07/06/26 10:31 AM ET
What is the market capitalization of Insulet Corporation - Common Stock?
The market capitalization of Insulet Corporation - Common Stock is 10.73B
How many shares of Insulet Corporation - Common Stock are outstanding?
Insulet Corporation - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.